Contents
Current Pharmaceutical Design, Volume 12 - Number 27
Expression, Distribution and Regulation of Phosphodiesterase 5
, 12(27): 3439 - 3457Ching-Shwun Lin, Guiting Lin, Zhong-Cheng Xin and Tom F. Lue
DOI: 10.2174/138161206778343064
Phosphodiesterase 5 Inhibitors - Drug Design and Differentiation Based on Selectivity, Pharmacokinetic and Efficacy Profiles
, 12(27): 3459 - 3465Claudiu T. Supuran, Antonio Mastrolorenzo, Giuseppe Barbaro and Andrea Scozzafava
DOI: 10.2174/138161206778343118
Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
, 12(27): 3467 - 3484Antonio Aversa, Roberto Bruzziches, Marcello Pili and Giovanni Spera
DOI: 10.2174/138161206778343046
Cardiovascular Effects of Phosphodiesterase 5 Inhibitors
, 12(27): 3485 - 3494Thorsten Reffelmann and Robert A. Kloner
DOI: 10.2174/138161206778343073
Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State
, 12(27): 3509 - 3519Yossi Gilgun-Sherki, Eldad Melamed and Daniel Offen
DOI: 10.2174/138161206778343091
Dual Effects of Antioxidants in Neurodegeneration: Direct Neuroprotection against Oxidative Stress and Indirect Protection via Suppression of Gliamediated Inflammation
, 12(27): 3521 - 3533Jia-Yi Wang, Li- Li Wen, Ya-Ni Huang, Yen-Tsun Chen and Min-Chi Ku
DOI: 10.2174/138161206778343109
Therapeutic Use of Nitric Oxide Scavengers in Shock and Sepsis
, 12(27): 3543 - 3549Brian G. Harbrecht
DOI: 10.2174/138161206778343000
Role of Nitric Oxide and Reactive Oxygen Species in Arthritis
, 12(27): 3551 - 3570Salvatore Cuzzocrea
DOI: 10.2174/138161206778343082
Webmaster Contact: info@benthamscience.org